In this study, we specifically investigated the microRNA-4716–3p, its target AKT2 gene, and rs2304186 variations of blood cancer patients alongside healthy individuals to discern potential biomarkers for non-invasive prognostic and diagnostic purposes. Here, AKT2 is linked to cancer.